LLY SLAMMED HARD MORE DOWNSIDE COMING TRADERS

Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/
1. Success of Weight-Loss Drugs: The company’s GLP-1 drugs, Zepbound and Mounjaro, have been highly successful in treating obesity and type 2 diabetes. These drugs have led to significant weight loss and improved glycemic control, positioning Eli Lilly as a leader in the multi-billion dollar weight-loss market1.
2. Promising Alzheimer’s Treatment: Eli Lilly’s investigational drug, donanemab, has shown promising results in slowing the progression of Alzheimer’s disease. Although it has some side effects, the FDA advisory committee recommended its approval, which has boosted investor confidence1.
3. Strong Financial Performance: Eli Lilly reported a 26% increase in revenue during the first quarter of 2024 compared to the same period last year. This strong financial performance has contributed to the stock’s upward trajectory1.
4. Positive Market Sentiment: Analysts have been bullish on Eli Lilly’s future prospects, with some raising their price targets significantly. This positive sentiment has further fueled the stock’s growth2.
Would you like to know more about any specific aspect of Eli Lilly’s business or its stock performance?

This is the TurboOptionTrading Youtube channel. We bring 35 years of market experience to our Youtube subscribers to show how to make money with daytrading. Join us as we do technical analysis, go over options strategies, examine market trends, identify setups and more.

Want to join the Turbo Option community and get even more hot stock picks? Visit turbooptiontrading.com. Turbo Option Trading is for traders of all experience levels from beginners to advanced market participants. We offer educational videos, one-on-one mentorship, a live trading room and even trading capital funded accounts for qualified users.